Anuja Bandyopadhyay1, Heidi Harmon2, James E Slaven3, Ameet S Daftary1. 1. Section of Pediatric Pulmonology, Allergy and Sleep Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana. 2. Section of Neonatal-Perinatal Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana. 3. Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana.
Abstract
STUDY OBJECTIVES: Neurocognitive deficits have been shown in school-aged children with sleep apnea. The effect of obstructive sleep apnea (OSA) on the neurodevelopmental outcome of preterm infants is unknown. METHODS: A retrospective chart review was performed for all preterm infants (< 37 weeks) who had neonatal polysomnography (PSG) and completed neurodevelopmental assessment with the Bayley Scales of Infant and Toddler Development, 3rd Edition, between 2006 to 2015 at Riley Hospital. Exclusion criteria included grade IV intraventricular hemorrhage, tracheostomy, cyanotic heart disease, severe retinopathy of prematurity, craniofacial anomalies, or central and mixed apnea on PSG. Sleep apnea was defined as an apnea-hypopnea index (AHI) > 1 event/h. Regression analyses were performed to find a relationship between PSG parameters and cognitive, language, and motor scores. RESULTS: Fifteen patients (males: n = 10) were eligible for the study. Median postmenstrual age at the time of the PSG was 41 weeks (37-46). Median AHI for the cohort was 17.4 events/h (2.2-41.3). Median cognitive, language, and motor scores were 90 (65-125), 89 (65-121), and 91 (61-112), respectively. Mean end-tidal CO2 (median 47 mm Hg [25-60]) negatively correlated with cognitive scores (P = .01) but did not significantly correlate with language or motor scores. AHI was not associated with cognitive, language, or motor scores. CONCLUSIONS: The median score for cognitive, language, and motor scores for preterm infants with neonatal OSA were within one standard deviation of the published norm. Mean end-tidal CO2, independent of AHI, may serve as a biomarker for predicting poor cognitive outcome in preterm infants with neonatal OSA. COMMENTARY: A commentary on this article appears in this issue on page 1233.
STUDY OBJECTIVES: Neurocognitive deficits have been shown in school-aged children with sleep apnea. The effect of obstructive sleep apnea (OSA) on the neurodevelopmental outcome of preterm infants is unknown. METHODS: A retrospective chart review was performed for all preterm infants (< 37 weeks) who had neonatal polysomnography (PSG) and completed neurodevelopmental assessment with the Bayley Scales of Infant and Toddler Development, 3rd Edition, between 2006 to 2015 at Riley Hospital. Exclusion criteria included grade IV intraventricular hemorrhage, tracheostomy, cyanotic heart disease, severe retinopathy of prematurity, craniofacial anomalies, or central and mixed apnea on PSG. Sleep apnea was defined as an apnea-hypopnea index (AHI) > 1 event/h. Regression analyses were performed to find a relationship between PSG parameters and cognitive, language, and motor scores. RESULTS: Fifteen patients (males: n = 10) were eligible for the study. Median postmenstrual age at the time of the PSG was 41 weeks (37-46). Median AHI for the cohort was 17.4 events/h (2.2-41.3). Median cognitive, language, and motor scores were 90 (65-125), 89 (65-121), and 91 (61-112), respectively. Mean end-tidal CO2 (median 47 mm Hg [25-60]) negatively correlated with cognitive scores (P = .01) but did not significantly correlate with language or motor scores. AHI was not associated with cognitive, language, or motor scores. CONCLUSIONS: The median score for cognitive, language, and motor scores for preterm infants with neonatal OSA were within one standard deviation of the published norm. Mean end-tidal CO2, independent of AHI, may serve as a biomarker for predicting poor cognitive outcome in preterm infants with neonatal OSA. COMMENTARY: A commentary on this article appears in this issue on page 1233.
Authors: Pauline F F Decima; Karinna L Fyfe; Alexsandria Odoi; Flora Y Wong; Rosemary S C Horne Journal: Sleep Med Date: 2015-03-14 Impact factor: 3.492
Authors: Daniel J Gottlieb; Cynthia Chase; Richard M Vezina; Timothy C Heeren; Michael J Corwin; Sanford H Auerbach; Debra E Weese-Mayer; Samuel M Lesko Journal: J Pediatr Date: 2004-10 Impact factor: 4.406
Authors: M H Sanders; N B Kern; J P Costantino; R A Stiller; P J Strollo; K A Studnicki; J A Coates; T J Richards Journal: Chest Date: 1994-08 Impact factor: 9.410
Authors: Sarah N Biggs; Lisa M Walter; Angela R Jackman; Lauren C Nisbet; Aidan J Weichard; Samantha L Hollis; Margot J Davey; Vicki Anderson; Gillian M Nixon; Rosemary S C Horne Journal: PLoS One Date: 2015-09-29 Impact factor: 3.240
Authors: Meera S Meerkov; Fauziya Hassan; Ronald D Chervin; John D Barks; Martha D Carlson; Renée A Shellhaas Journal: Pediatr Pulmonol Date: 2019-01-27